Tenderwize
Wróć do wyszukiwania

Discount agreement for Calcipotriol/Betamethasone cream

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Erfurt, Germany·Deadline May 31, 2028 · 643 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Calcipotriol/Betamethason - Creme (amtlicher ATC-Code: D05AX22)

30/100

Ocena szansy

Needs reviewLow complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

30 / 100

Złożoność

20 / 100

Czynniki ryzyka

No guaranteed purchase quantities; actual demand is uncertain and dependent on physician prescribing and pharmacy prefe...

The authority may terminate the Open-House process early if exclusive discount agreements are concluded, typically with...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Supply of Calcipotriol/Betamethasone cream (ATC D05AX22) as a pharmaceutical product
  • Conclusion of non-exclusive discount agreements under § 130a Abs. 8 SGB V
Pokaż pełne podsumowanie

This is an Open-House model (non-competitive) for non-exclusive drug discount agreements under § 130a Abs. 8 SGB V for the active substance Calcipotriol/Betamethasone (ATC D05AX22) in cream form. The contracting authority is AOK PLUS for Saxony and Thuringia, Germany. The agreement runs until 31 May 2028, with no guarantee of minimum purchase quantities. The tender is published voluntarily on TED for transparency; it is not a public procurement subject to EU directives. Important: the discount terms are confidential and only accessible after requesting access to the DTVP project room.

Ryzyka

No guaranteed purchase quantities; actual demand is uncertain and dependent on physician prescribing and pharmacy prefe...

The authority may terminate the Open-House process early if exclusive discount agreements are concluded, typically with...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical entrepreneur as per § 4 Abs. 18 AMG with respect to the offered medicinal product
  • Must have registered seat in Germany, EU, or EEA (§ 9 Abs. 2 AMG)

Eligibility

  • Submit self-declaration on exclusion grounds (§§ 123, 124 GWB)

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No explicit award criteria provided; the agreement is based on acceptance of the discount terms, not on competitive scoring.

Zamawiający

Lokalizacja

Erfurt, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE256878834

Działalność

Health

Części (1)

LOT-0001

Discount agreement for Calcipotriol/Betamethasone cream

Non-exclusive discount agreement for the supply of Calcipotriol/Betamethasone cream. Open to all qualified pharmaceutical entrepreneurs who accept the terms. No individual negotiations; no exclusivity. No guaranteed volumes.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

Dresden, Germany

Czas trwania

May 2026 - May 2028

Kategoria

Pharmaceutical products

Kryteria udzielenia

No explicit award criteria provided; the agreement is based on acceptance of the discount terms, not on competitive scoring.

Termin

Deadline May 31, 2028

Szczegóły zamówienia

Data publikacji
25 Mar 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
207477-2026

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3